Kanteron Systems

Kanteron Systems was a privately held healthcare IT and computational bioinformatics company founded in 2005 and closed in 2021, headquartered in Valencia, Spain, with offices in Madrid. The company developed a clinical content management platform designed to help healthcare providers manage, integrate, and analyse imaging and genomic data for precision medicine applications at the point of care. Its stated mission was to organise clinical information and make it accessible and useful, with the goal of enabling earlier disease detection. During its operational period, the platform was deployed over 500 times across 15 countries, serving large healthcare networks including the NHS in the United Kingdom, ISSSTE and IMSS in Mexico, and EsSalud in Peru.

The Kanteron Platform addressed a recognised challenge in precision medicine: the integration of disparate clinical data systems and clinical genomic data. The platform ingested medical images, digital pathology slides, genomic sequences, and patient data from modalities, scanners, sequencers, and databases, and provided a unified data toolkit to clinical teams across hospital networks. In total, the platform managed more than 750 million medical images, over 4 million clinical reports, and more than 200 terabytes of data.

Core Platform Modules

• PACS-VNA / Radiology: A picture archiving and communication system combined with vendor-neutral archive capabilities, including PACS, RIS, workstation, and zero-footprint viewer (ZFPV) functionality.
• Digital Pathology: A vendor-neutral dicomizer for whole slide imaging, enabling digital pathology workflows.
• Clinical Genomics: Support for next-generation sequencing (NGS) and VCF data formats for clinical genomic analysis.
• Pharmacogenomics: Tools for analysing DNA-medication interactions to support personalised prescribing decisions.
• AI/ML and Big Data Analytics: Dashboards and reporting tools incorporating artificial intelligence and machine learning algorithms, including third-party algorithm integration.
• Telemedicine and Collaboration: Support for teleradiology, telepathology, telegenomics, teleconsultation, multidisciplinary team (MDT) meetings, and molecular tumour boards.

Key Capabilities

• Ingest and store: Data could be stored on-site or within a private cloud, keeping patient data within the hospital environment if required.
• Integrate: The platform used open-source components and healthcare standards to connect disparate data sources.
• Analyse: AI and machine learning tools, as well as third-party algorithms, could be applied to integrated data sets.
• Visualise and report: Zero-footprint progressive (ZFP) viewing and synoptic reporting were accessible via a standard web browser.
• 360-degree patient view: The platform aggregated prior studies, multi-specialty synoptic reports, images, and analyses into a unified patient record.
• Continuum of care coordination: Tools supported care coordination across multidisciplinary teams and clinical settings.

Recognition and Notable Feedback

• Kanteron received the Frost & Sullivan Technology Innovation Award for Precision Medicine Platform, with Frost & Sullivan noting the platform's ability to curate, integrate, and report diverse data streams and provide advanced predictive analytics.
• Representatives from the British Medical Journal, Fraunhofer Institute, Accenture, Oxford Academic Health Science Network, MD Anderson Cancer Center, and Great Ormond Street Hospital NHS each provided positive assessments of the platform.
• HIMSS Analytics and the Journal of the American Medical Association (JAMA) were cited in relation to the core challenge the platform addressed: integrating clinical data systems with clinical genomic data.

Team and Leadership

• Jorge Cortell – Founder and CEO; serial entrepreneur with a computing doctorate from Oxford and an entrepreneurship programme at MIT; former visiting professor and EU Commission expert.
• John Memarian – President and CSO; background in cardiology tech support and executive roles at Merge (acquired by IBM), General Electric, McKesson, Leidos, Mach7 Technologies, and HP/Agilent.
• Juan Tatay – COO; completed executive development programmes at MIT and Cambridge.
• Alvaro Gonzalez – CTO; certified Google Cloud Architect with a background in medical imaging and cloud architecture.
• Santiago Gala – Senior VP Systems Architecture; MSc in Quantum Chemistry and Systems Engineering; former AI lead at the European Space Agency and Chairman of the Apache Software Foundation portals.
• Pablo Marin, PhD – Senior VP Bioinformatics; PhD in Biology; former roles at EMBL-EBI, Wellcome Trust Sanger Institute, and the Institute of Genomic Medicine.
• Luis Alario – Senior VP Software; PACS-RIS and HL7 expert with a BSc in Computer Science.
• Additional team members covered bioinformatics, pharmacogenomics, data science, software development, and regional technical support across Latin America and Asia-Pacific.

Deployment and Geographic Reach

• The platform was deployed more than 500 times across 15 countries on 5 continents.
• Customers included major national health systems and hospital networks in the UK, Mexico, and Peru, among others.
• Regional directors covered Latin America and Asia-Pacific, with the Asia-Pacific director having prior experience at IBM Watson Health, Siemens Healthcare, and HP Medical.
• The company was incorporated as Kanteron Systems S.L.U. and operated from 2005 to 2021.

Kanteron Systems is no longer operational as of 2021, though its website notes that its technology continues in some form. The company's profile was listed across multiple startup and healthcare IT directories, and it maintained partnerships with a range of organisations during its operational period.